908 CHARACTERISTICS OF A COST-EFFECTIVE BLOOD TEST FOR COLORECTAL CANCER SCREENING
Leggi →
Maggio 2024
Risultati per: Nuovo test del sangue per la diagnosi di cancro alla prostata
Questo è quello che abbiamo trovato per te
Sa1130 MULTICHANNEL RECRUITMENT ENABLED BROAD GEOGRAPHICAL REACH IN AN AVERAGE RISK POPULATION SCREENING STUDY FOR A BLOOD BASED TEST FOR THE EARLY DETECTION OF COLORECTAL CANCER
Leggi →
Maggio 2024
Sa1131 DIAGNOSTIC PERFORMANCE OF QUANTITATIVE FECAL IMMUNOCHEMICAL TEST FOR COLORECTAL CANCER; THE EFFECTS OF ONE-DAY VERSUS TWO DAY TEST
Leggi →
Maggio 2024
Sa1124 POSITIVITY OF FECAL IMMUNOCHEMICAL TEST IN THE LARGEST SAMPLE OF AVERAGE RISK OF COLORECTAL CANCER MEXICANS.
Leggi →
Maggio 2024
410 TEMPORAL CHANGE OF T1N1 STAGE III COLORECTAL CANCER IN THE CONTEXT OF FECAL IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER SCREENING PROGRAM IMPLEMENTATION AND ITS POTENTIAL IMPACT ON SCREENING EFFECTIVENESS
Leggi →
Maggio 2024
Sa1247 CLINICAL MONITORING OF EOSINOPHILIC ESOPHAGITIS USING THE ESOPHAGEAL STRING TEST
Leggi →
Maggio 2024
1090 RISK PREDICTION FOR COLORECTAL CANCER USING QUANTITATIVE FECAL IMMUNOCHEMICAL TEST RESULTS — A STATISTICAL SOLUTION TO THE COLONOSCOPY CAPACITY ISSUE
Leggi →
Maggio 2024
1086 THE ASSOCIATION BETWEEN LETTER TYPE AND FECAL IMMUNOCHEMICAL TEST COMPLETION IN A POPULATION HEALTH OUTREACH PROGRAM
Leggi →
Maggio 2024
1168 DIFFERENTIATING PANCREATIC CYSTS THROUGH FLUID GLUCOSE UTILIZING A VALIDATED LABORATORY GLUCOSE TEST IN A PROSPECTIVE COHORT STUDY
Leggi →
Maggio 2024
477 EFFECTIVENESS OF COMPLETING MAILED SCREENING FECAL IMMUNOCHEMICAL TEST ON RISK OF DYING FROM COLORECTAL CANCER.
Leggi →
Maggio 2024
473 RANDOMIZED CONTROLLED TRIAL OF FECAL IMMUNOCHEMICAL TEST (FIT)-BASED MAILED OUTREACH OFFERING ACTIVE CHOICE (FIT OR COLONOSCOPY UP-FRONT) VS. SEQUENTIAL CHOICE (INITIAL FIT, LATER INVITATION FOR COLONOSCOPY) FOR COLORECTAL CANCER (CRC) SCREENING
Leggi →
Maggio 2024
395 FAECAL IMMUNOCHEMICAL TEST TO DETECT COLORECTAL NEOPLASIA IN LYNCH SYNDROME – A PROSPECTIVE MULTICENTRE STUDY
Leggi →
Maggio 2024
Sa1118 RISK OF COLORECTAL CANCER AMONG FECAL IMMUNOCHEMICAL TEST-POSITIVE INDIVIDUALS BY TIMING OF PREVIOUS COLONOSCOPY: A JAPANESE MULTICENTER ANALYSIS
Leggi →
Maggio 2024
1087 FECAL IMMUNOCHEMICAL TEST UPTAKE AND YIELD IN PATIENTS AGES 45-49 VERSUS 50 YEARS IN THE FIRST YEAR AFTER LOWERING THE AGE OF COLORECTAL CANCER SCREENING INITIATION
Leggi →
Maggio 2024
Sa1815 A FECAL CALPROTECTIN CUTOFF OF 50 UG/G IS ASSOCIATED WITH ENDOSCOPIC RECURRENCE IN LOW PRE-TEST PROBABILITY PATIENTS WITH CROHN'S DISEASE AFTER ILEOCOLIC RESECTION
Leggi →
Maggio 2024
Su1111 ANALYZING ADHERENCE TO CLINICAL GUIDELINES ON COLORECTAL CANCER SCREENING FOLLOW UP: FACTORS INFLUENCING LACK OF COLONOSCOPY AFTER AN ABNORMAL STOOL OCCULT BLOOD TEST RESULT
Leggi →
Maggio 2024
